A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users

To evaluate whether a behavioral intervention, which taught peer education skills, could reduce injection and sexual risk behaviors associated with primary HIV and hepatitis C virus infection (HCV) among young injection drug users (IDU). We conducted a randomized controlled trial involving HIV and H...

Full description

Saved in:
Bibliographic Details
Published inAIDS (London) Vol. 21; no. 14; pp. 1923 - 1932
Main Authors GARFEIN, Richard S, GOLUB, Elizabeth T, STRATHDEE, Steffanie A, THIEDE, Hanne, GREENBERG, Alan E, HAGAN, Holly, HANSON, Debra L, HUDSON, Sharon M, KAPADIA, Farzana, LATKA, Mary H, OUELLET, Lawrence J, PURCELL, David W
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Lippincott Williams & Wilkins 12.09.2007
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To evaluate whether a behavioral intervention, which taught peer education skills, could reduce injection and sexual risk behaviors associated with primary HIV and hepatitis C virus infection (HCV) among young injection drug users (IDU). We conducted a randomized controlled trial involving HIV and HCV antibody-negative IDU, aged 15-30 years, recruited in five United States cities. A six-session, small-group, cognitive behavioral, skills-building intervention in which participants were taught peer education skills (n = 431) was compared with a time-equivalent attention control (n = 423). Baseline visits included interviews for sociodemographic, psychosocial, and behavioral factors during the previous 3 months; HIV and HCV antibody testing; and pre/posttest counselling. Procedures were repeated 3 and 6 months postintervention. The intervention produced a 29% greater decline in overall injection risk 6 months postintervention relative to the control [proportional odds ratio 0.71; 95% confidence limit (CL) 0.52, 0.97], and a 76% decrease compared with baseline. Decreases were also observed for sexual risk behaviors, but they did not differ by trial arm. Overall HCV infection incidence (18.4/100 person-years) did not differ significantly across trial arms (relative risk 1.15; 95% CL 0.72, 1.82). No HIV seroconversions were observed. Interventions providing information, enhancing risk-reduction skills, and motivating behavior change through peer education training can reduce injection risk behaviors, although risk elimination might be necessary to prevent HCV transmission.
AbstractList To evaluate whether a behavioral intervention, which taught peer education skills, could reduce injection and sexual risk behaviors associated with primary HIV and hepatitis C virus infection (HCV) among young injection drug users (IDU). We conducted a randomized controlled trial involving HIV and HCV antibody-negative IDU, aged 15-30 years, recruited in five United States cities. A six-session, small-group, cognitive behavioral, skills-building intervention in which participants were taught peer education skills (n = 431) was compared with a time-equivalent attention control (n = 423). Baseline visits included interviews for sociodemographic, psychosocial, and behavioral factors during the previous 3 months; HIV and HCV antibody testing; and pre/posttest counselling. Procedures were repeated 3 and 6 months postintervention. The intervention produced a 29% greater decline in overall injection risk 6 months postintervention relative to the control [proportional odds ratio 0.71; 95% confidence limit (CL) 0.52, 0.97], and a 76% decrease compared with baseline. Decreases were also observed for sexual risk behaviors, but they did not differ by trial arm. Overall HCV infection incidence (18.4/100 person-years) did not differ significantly across trial arms (relative risk 1.15; 95% CL 0.72, 1.82). No HIV seroconversions were observed. Interventions providing information, enhancing risk-reduction skills, and motivating behavior change through peer education training can reduce injection risk behaviors, although risk elimination might be necessary to prevent HCV transmission.
Objectives: To evaluate whether a behavioral intervention, which taught peer education skills, could reduce injection and sexual risk behaviors associated with primary HIV and hepatitis C virus infection (HCV) among young injection drug users (IDU). Design: We conducted a randomized controlled trial involving HIV and HCV antibody-negative IDU, aged 15-30 years, recruited in five United States cities. A six-session, small-group, cognitive behavioral, skills-building intervention in which participants were taught peer education skills (n=431) was compared with a time-equivalent attention control (n=423). Baseline visits included interviews for sociodemographic, psychoso-cial, and behavioral factors during the previous 3 months; HIV and HCV antibody testing; and pre/posttest counselling. Procedures were repeated 3 and 6 months postintervention. Results: The intervention produced a 29% greater decline in overall injection risk 6 months postintervention relative to the control [proportional odds ratio 0.71; 95% confidence limit (CL) 0.52, 0.97], and a 76% decrease compared with baseline. Decreases were also observed for sexual risk behaviors, but they did not differ by trial arm. Overall HCV infection incidence (18.4/100 person-years) did not differ significantly across trial arms (relative risk 1.15; 95% CL 0.72, 1.82). No HIV seroconversions were observed. Conclusion: Interventions providing information, enhancing risk-reduction skills, and motivating behavior change through peer education training can reduce injection risk behaviors, although risk elimination might be necessary to prevent HCV transmission.
Author THIEDE, Hanne
LATKA, Mary H
GOLUB, Elizabeth T
OUELLET, Lawrence J
PURCELL, David W
GREENBERG, Alan E
STRATHDEE, Steffanie A
HAGAN, Holly
HANSON, Debra L
HUDSON, Sharon M
KAPADIA, Farzana
GARFEIN, Richard S
Author_xml – sequence: 1
  givenname: Richard S
  surname: GARFEIN
  fullname: GARFEIN, Richard S
  organization: Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States
– sequence: 2
  givenname: Elizabeth T
  surname: GOLUB
  fullname: GOLUB, Elizabeth T
  organization: Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, United States
– sequence: 3
  givenname: Steffanie A
  surname: STRATHDEE
  fullname: STRATHDEE, Steffanie A
  organization: University of California San Diego, School of Medicine, San Diego, California, United States
– sequence: 4
  givenname: Hanne
  surname: THIEDE
  fullname: THIEDE, Hanne
  organization: Public Health Seattle and King County, Seattle, Washington, United States
– sequence: 5
  givenname: Alan E
  surname: GREENBERG
  fullname: GREENBERG, Alan E
  organization: Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States
– sequence: 6
  givenname: Holly
  surname: HAGAN
  fullname: HAGAN, Holly
  organization: National Research and Development Institutes, New York, New York, United States
– sequence: 7
  givenname: Debra L
  surname: HANSON
  fullname: HANSON, Debra L
  organization: Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States
– sequence: 8
  givenname: Sharon M
  surname: HUDSON
  fullname: HUDSON, Sharon M
  organization: Health Research Association, Los Angeles, California, United States
– sequence: 9
  givenname: Farzana
  surname: KAPADIA
  fullname: KAPADIA, Farzana
  organization: New York Academy of Medicine, Center for Urban Epidemiologic Studies, New York, New York, United States
– sequence: 10
  givenname: Mary H
  surname: LATKA
  fullname: LATKA, Mary H
  organization: New York Academy of Medicine, Center for Urban Epidemiologic Studies, New York, New York, United States
– sequence: 11
  givenname: Lawrence J
  surname: OUELLET
  fullname: OUELLET, Lawrence J
  organization: University of Illinois at Chicago, School of Public Health, Chicago, Illinois, United States
– sequence: 12
  givenname: David W
  surname: PURCELL
  fullname: PURCELL, David W
  organization: Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19135567$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/17721100$$D View this record in MEDLINE/PubMed
BookMark eNpdkE1PGzEQhq0KVBLgH1SVL-1tYWzv2tljFMqHhISQgOvKa48T08RO7d1I_AF-NxtYiYrTaGae9z08U3IQYkBCfjA4Y1Cr8_v5xRm0wAQKPuPC1SDlNzJhpRJFVSl2QCbAZV3UQsERmeb8DAAVzGbfyRFTijMGMCGvc7pFTAXa3ujOx0B96DDtMLwvXaRp_8Lh_Izm_ZZ8_ktbXOmdjylTFxO9vnmiOli6wu1Q0vlMF3TnU5-HmBtjPtCX2Iflf0029UvaZ0z5hBw6vc54Os5j8nj552FxXdzeXd0s5reFKRnvipY5AIecG6OkrWcW21Y5WzuhJJZKi4rXEtEow7SWUlpujbWtdq0smdFGHJPfH73bFP_1mLtm47PB9VoHjH1uOAOhyooPYPkBmhRzTuiabfIbnV4aBs3efzP4b776H2I_x_6-3aD9DI3CB-DXCOhs9NolHYzPn1zNRFVJJd4AGBWUYw
CitedBy_id crossref_primary_10_1111_j_1478_3231_2011_02494_x
crossref_primary_10_1016_j_drugalcdep_2009_07_005
crossref_primary_10_21859_nmj_25025
crossref_primary_10_1177_2325957415613442
crossref_primary_10_1016_j_asoc_2012_02_020
crossref_primary_10_3109_10826084_2011_521466
crossref_primary_10_1016_j_drugalcdep_2015_03_002
crossref_primary_10_1080_09540121_2022_2085868
crossref_primary_10_1080_13548506_2010_498890
crossref_primary_10_1007_s11524_015_9995_7
crossref_primary_10_3109_10826081003682875
crossref_primary_10_1007_s10461_013_0601_2
crossref_primary_10_1016_j_jsat_2014_07_002
crossref_primary_10_1186_s12889_021_12104_w
crossref_primary_10_3109_10826080903452439
crossref_primary_10_3109_10826084_2012_644122
crossref_primary_10_1093_ofid_ofz160
crossref_primary_10_1016_j_vaccine_2024_05_076
crossref_primary_10_1136_bmjopen_2013_002581
crossref_primary_10_1371_journal_pone_0228471
crossref_primary_10_2174_1874613601004030105
crossref_primary_10_1002_cl2_1264
crossref_primary_10_1111_dar_13134
crossref_primary_10_1007_s11524_015_9988_6
crossref_primary_10_1186_s12954_018_0245_7
crossref_primary_10_1016_j_drugpo_2013_03_004
crossref_primary_10_1136_bmjopen_2020_041482
crossref_primary_10_1016_j_drugpo_2018_02_004
crossref_primary_10_1007_s10461_018_2293_0
crossref_primary_10_1097_OLQ_0b013e318186dee3
crossref_primary_10_3390_ijerph19073783
crossref_primary_10_1186_s12954_017_0142_5
crossref_primary_10_1016_S2468_1253_23_00018_3
crossref_primary_10_1016_j_drugpo_2023_104250
crossref_primary_10_1016_j_drugalcdep_2013_08_007
crossref_primary_10_1016_j_meegid_2018_05_028
crossref_primary_10_1007_s10461_021_03275_z
crossref_primary_10_1007_s10461_009_9569_3
crossref_primary_10_1007_s10461_017_1755_0
crossref_primary_10_1016_j_socscimed_2008_09_061
crossref_primary_10_2105_AJPH_2007_113415
crossref_primary_10_1556_oh_2010_28860
crossref_primary_10_1016_j_drugalcdep_2007_05_007
crossref_primary_10_1016_j_drugpo_2008_02_015
crossref_primary_10_1007_s12664_013_0407_1
crossref_primary_10_1093_cid_ciu698
crossref_primary_10_1186_s12954_017_0192_8
crossref_primary_10_1371_journal_pmed_1000329
crossref_primary_10_1371_journal_pone_0065812
crossref_primary_10_1111_j_1360_0443_2011_03765_x
crossref_primary_10_1080_02739615_2023_2231339
crossref_primary_10_1016_j_drugpo_2014_07_013
crossref_primary_10_1371_journal_pone_0019048
crossref_primary_10_1016_j_drugpo_2011_08_002
crossref_primary_10_1080_09540121_2010_525608
crossref_primary_10_2174_1874613601206010259
crossref_primary_10_1177_009145091003700405
crossref_primary_10_3748_wjg_v20_i36_12722
crossref_primary_10_1186_s12954_016_0108_z
crossref_primary_10_1007_s10461_011_9943_9
crossref_primary_10_1080_15381501_2016_1244653
crossref_primary_10_1007_s10461_013_0488_y
crossref_primary_10_1097_QAD_0b013e3282f3cc5d
crossref_primary_10_1186_s12879_020_05003_9
crossref_primary_10_1002_jmv_23252
crossref_primary_10_1016_j_vaccine_2010_08_085
crossref_primary_10_1007_s11904_021_00556_z
crossref_primary_10_4137_SART_S580
crossref_primary_10_1177_009145091003700407
crossref_primary_10_1007_s10461_011_0125_6
crossref_primary_10_1017_S0950268812000696
crossref_primary_10_1371_journal_pone_0131712
crossref_primary_10_1007_s10461_013_0660_4
crossref_primary_10_1186_1471_2458_10_401
crossref_primary_10_1016_j_drugalcdep_2011_10_009
crossref_primary_10_11604_pamj_2019_34_214_12851
crossref_primary_10_1007_s10461_012_0373_0
crossref_primary_10_1016_j_socscimed_2008_11_019
crossref_primary_10_1007_s10461_017_1774_x
crossref_primary_10_1097_QAD_0b013e3282f3cc4d
crossref_primary_10_1016_j_drugalcdep_2007_08_010
crossref_primary_10_1016_j_addbeh_2017_07_017
crossref_primary_10_1111_j_1360_0443_2011_03749_x
crossref_primary_10_1007_s10461_020_03115_6
crossref_primary_10_1093_infdis_jiq111
crossref_primary_10_1007_s11524_012_9718_2
crossref_primary_10_1016_j_drugpo_2022_103930
crossref_primary_10_1136_bmjopen_2014_004988
crossref_primary_10_1177_1090198109357319
crossref_primary_10_1016_j_drugalcdep_2007_11_020
crossref_primary_10_1016_j_socscimed_2013_07_006
crossref_primary_10_1186_1747_597X_7_47
crossref_primary_10_1016_j_drugpo_2021_103319
crossref_primary_10_1016_j_addbeh_2015_01_020
crossref_primary_10_1007_s10903_009_9308_x
crossref_primary_10_3310_hta21720
crossref_primary_10_1016_j_genhosppsych_2010_02_001
crossref_primary_10_1016_j_epidem_2008_10_002
crossref_primary_10_1097_QAD_0b013e3283467198
crossref_primary_10_1371_journal_pone_0183354
crossref_primary_10_1016_j_drugpo_2014_01_009
crossref_primary_10_1071_NB10007
crossref_primary_10_3389_fpsyt_2022_905314
crossref_primary_10_1186_s12954_023_00789_8
crossref_primary_10_1186_1471_2458_12_653
crossref_primary_10_1002_14651858_CD007381_pub2
crossref_primary_10_1177_0017896916641459
crossref_primary_10_1016_j_addbeh_2011_03_014
crossref_primary_10_1093_infdis_jir196
crossref_primary_10_1002_14651858_CD012021_pub2
crossref_primary_10_1186_1471_2458_14_645
crossref_primary_10_1111_j_1360_0443_2010_03251_x
crossref_primary_10_1186_1471_2458_11_610
Cites_doi 10.1136/bmj.38286.841227.7C
10.5694/j.1326-5377.1993.tb137822.x
10.1006/pmed.1994.1056
10.1093/aje/152.2.99
10.2105/AJPH.81.5.568
10.1097/00005792-199507000-00005
10.1111/j.1360-0443.1997.tb02852.x
10.1017/CBO9780511814365
10.1097/00002030-199204000-00013
10.1016/S0899-3289(01)00071-2
10.1093/oxfordjournals.aje.a116489
10.1086/345554
10.1007/s10461-005-1679-y
10.2105/AJPH.91.1.42
10.1001/archinte.161.10.1281
10.1016/j.drugalcdep.2004.01.014
10.1097/01.aids.0000196166.48518.a0
10.1111/j.1360-0443.2004.00963.x
10.1136/jech.57.4.310
10.1097/00042560-199802001-00004
10.1093/aje/155.7.645
10.1126/science.280.5365.867
10.1097/00002030-199008000-00020
10.1037/0033-2909.111.3.455
10.1136/bmj.317.7156.433
10.1093/jurban/jtg078
10.2105/AJPH.81.2.168
10.1001/archinte.1995.00430120091011
10.1093/oxfordjournals.aje.a116275
10.1111/j.1360-0443.1993.tb02094.x
10.2105/AJPH.82.4.533
10.2105/AJPH.86.5.655
10.1016/S0140-6736(98)07026-3
10.1056/NEJM200107053450107
10.1097/00002030-199305000-00017
10.1093/her/7.3.403
10.1093/aje/kwf222
10.1056/NEJM198909283211306
10.2307/2529876
10.2307/1912557
10.1016/S0140-6736(00)04562-1
ContentType Journal Article
Copyright 2007 INIST-CNRS
Copyright_xml – notice: 2007 INIST-CNRS
CorporateAuthor DUIT Study Team
CorporateAuthor_xml – name: DUIT Study Team
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T2
7T5
7U1
7U2
7U9
C1K
H94
DOI 10.1097/QAD.0b013e32823f9066
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Health and Safety Science Abstracts (Full archive)
Immunology Abstracts
Risk Abstracts
Safety Science and Risk
Virology and AIDS Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Risk Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
Health & Safety Science Abstracts
Immunology Abstracts
Safety Science and Risk
Environmental Sciences and Pollution Management
DatabaseTitleList MEDLINE
Risk Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1473-5571
EndPage 1932
ExternalDocumentID 10_1097_QAD_0b013e32823f9066
17721100
19135567
Genre Randomized Controlled Trial
Research Support, U.S. Gov't, P.H.S
Journal Article
GeographicLocations United States
North America
America
USA
GeographicLocations_xml – name: United States
– name: USA
GrantInformation_xml – fundername: PHS HHS
  grantid: U64/CCU017615
– fundername: PHS HHS
  grantid: U64/CCU317662
– fundername: PHS HHS
  grantid: U64 CCU217659
– fundername: PHS HHS
  grantid: U64/CCU517656
– fundername: PHS HHS
  grantid: U64/CCU917655
GroupedDBID ---
.GJ
.XZ
.Z2
01R
08R
0R~
1CY
1J1
23M
2WC
354
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
71W
77Y
7O~
85S
8L-
AAAXR
AAGIX
AAHPQ
AAJCS
AAMOA
AAMTA
AAPBV
AAQKA
AARTV
AASOK
AASXQ
AAXQO
ABASU
ABBUW
ABDIG
ABIVO
ABXVJ
ABZAD
ACCJW
ACDDN
ACEWG
ACGFS
ACILI
ACOAL
ACWDW
ACWRI
ACXNZ
ADBBV
ADFPA
ADGGA
ADNKB
AE3
AE6
AEBDS
AEETU
AENEX
AFDTB
AFFNX
AFUWQ
AGINI
AHOMT
AHRYX
AHVBC
AIJEX
AJIOK
AJNWD
AJNYG
AKALU
AKULP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AWKKM
BAWUL
BOYCO
BQLVK
BS7
BYPQX
C45
CAG
COF
CS3
DIK
DIWNM
DUNZO
E.X
E3Z
EBS
EEVPB
EJD
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FW0
GNXGY
GQDEL
H0~
HZ~
IKREB
IKYAY
IN~
IPNFZ
IQODW
JF9
JG8
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
L7B
N4W
N9A
N~7
N~B
N~M
O9-
OAG
OAH
OBH
OCUKA
ODA
ODMTH
OHH
OHYEH
OJAPA
OK1
OL1
OLB
OLG
OLH
OLU
OLV
OLW
OLY
OLZ
OPUJH
OPX
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
R58
RIG
RLZ
S4R
S4S
SJN
T8P
TEORI
TR2
TSPGW
UAP
V2I
VVN
W3M
WOQ
WOW
X3V
X3W
XJT
XXN
XYM
YFH
ZGI
ZXP
ZZMQN
AAAAV
AAIQE
AAUEB
ABJNI
ADHPY
AFEXH
AHQNM
AINUH
AJZMW
CGR
CUY
CVF
ECM
EIF
NPM
AASCR
AAYXX
ABVCZ
ACXJB
AFSOK
CITATION
ERAAH
HLJTE
7T2
7T5
7U1
7U2
7U9
C1K
H94
ID FETCH-LOGICAL-c412t-b1f00fe22cc76d98debb7fd9f376e47a35296eec7c1aa666d2dcddbafb641cac3
ISSN 0269-9370
IngestDate Fri Oct 25 12:15:03 EDT 2024
Fri Aug 23 00:26:48 EDT 2024
Tue Oct 15 23:29:14 EDT 2024
Sun Oct 22 16:04:58 EDT 2023
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 14
Keywords Intravenous administration
Hepatic disease
Epidemiology
Incidence
Education
Behavior
Viral hepatitis C
injection drug use
Human
Immunopathology
Drug addiction
AIDS
peer education
Immune deficiency
randomized controlled trial
Infection
Virus
HIV
Viral disease
Young adult
Risk factor
Digestive diseases
Flaviviridae
Hepatitis C virus
Hepacivirus
Arm
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c412t-b1f00fe22cc76d98debb7fd9f376e47a35296eec7c1aa666d2dcddbafb641cac3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doi.org/10.1097/qad.0b013e32823f9066
PMID 17721100
PQID 21037452
PQPubID 23462
PageCount 10
ParticipantIDs proquest_miscellaneous_21037452
crossref_primary_10_1097_QAD_0b013e32823f9066
pubmed_primary_17721100
pascalfrancis_primary_19135567
PublicationCentury 2000
PublicationDate 2007-09-12
PublicationDateYYYYMMDD 2007-09-12
PublicationDate_xml – month: 09
  year: 2007
  text: 2007-09-12
  day: 12
PublicationDecade 2000
PublicationPlace Hagerstown, MD
PublicationPlace_xml – name: Hagerstown, MD
– name: England
PublicationTitle AIDS (London)
PublicationTitleAlternate AIDS
PublicationYear 2007
Publisher Lippincott Williams & Wilkins
Publisher_xml – name: Lippincott Williams & Wilkins
References 17721105 - AIDS. 2007 Sep 12;21(14):1967-9
18097240 - AIDS. 2008 Jan 11;22(2):319; author reply 319
Crepaz (R55-12-20210130) 2006; 20
Becker Buxton (R48-12-20210130) 2004; 75
Crofts (R3-12-20210130) 1993; 159
Watkins (R29-12-20210130) 1993; 7
Bandura (R42-12-20210130) 1986
Strathdee (R15-12-20210130) 2001; 161
Strathdee (R32-12-20210130) 1997; 92
Wolfinger (R52-12-20210130) 2004
Neaigus (R31-12-20210130) 1995
Barnard (R30-12-20210130) 1993; 88
Judd (R7-12-20210130) 2005; 330
Turner (R45-12-20210130) 1998; 280
Smyth (R6-12-20210130) 2003; 57
Koester (R13-12-20210130) 2005; 9
Nicolosi (R19-12-20210130) 1992; 135
Lauer (R56-12-20210130) 2001; 345
Stephens (R25-12-20210130) 1991; 81
Fisher (R43-12-20210130) 1992; 111
Des Jarlais (R46-12-20210130) 1999; 353
Kral (R17-12-20210130) 2001; 357
Thorpe (R10-12-20210130) 2002; 155
Van Ameijden (R20-12-20210130) 1992; 136
McClusker (R26-12-20210130) 1992; 82
Hagan (R9-12-20210130) 2001; 91
Garfein (R18-12-20210130) 1998; 18
Metzger (R47-12-20210130) 2000; 152
Nelson (R21-12-20210130) 1995; 155
Vuong (R54-12-20210130) 1989; 57
Laird (R51-12-20210130) 1982; 38
Kelly (R34-12-20210130) 1991; 81
Schoenbaum (R14-12-20210130) 1989; 321
Thomas (R4-12-20210130) 1995; 74
Grund (R12-12-20210130) 1990; 4
Kauth (R37-12-20210130) 1993; 34
Des Jarlais (R23-12-20210130) 2003; 157
Hahn (R11-12-20210130) 2002; 186
McCullagh (R50-12-20210130) 1980; 42
Cameron (R53-12-20210130) 1998
Sullivan (R1-12-20210130) 2005; 100
(R41-12-20210130) 2001; 50
Main (R38-12-20210130) 1994; 23
Broadhead (R39-12-20210130) 1998; 113
Hansen (R36-12-20210130) 1992; 7
Van Beek (R8-12-20210130) 1998; 317
Garfein (R5-12-20210130) 1996; 86
Strathdee (R16-12-20210130) 2003; 80
Chamot (R2-12-20210130) 1992; 6
Neaigus (R24-12-20210130) 1990; 2
Latkin (R35-12-20210130) 1998; 113
Latka (R22-12-20210130) 2001; 13
References_xml – volume: 330
  start-page: 24
  year: 2005
  ident: R7-12-20210130
  article-title: Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study
  publication-title: BMJ
  doi: 10.1136/bmj.38286.841227.7C
  contributor:
    fullname: Judd
– volume: 159
  start-page: 237
  year: 1993
  ident: R3-12-20210130
  article-title: Hepatitis C virus infection among a cohort of Victorian injecting drug users
  publication-title: Med J Aust
  doi: 10.5694/j.1326-5377.1993.tb137822.x
  contributor:
    fullname: Crofts
– volume: 23
  start-page: 409
  year: 1994
  ident: R38-12-20210130
  article-title: Preventing HIV infection among adolescents: evaluation of a school-based education program
  publication-title: Prev Med
  doi: 10.1006/pmed.1994.1056
  contributor:
    fullname: Main
– volume: 152
  start-page: 99
  year: 2000
  ident: R47-12-20210130
  article-title: Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/152.2.99
  contributor:
    fullname: Metzger
– volume: 81
  start-page: 568
  year: 1991
  ident: R25-12-20210130
  article-title: Effects of an intervention program on AIDS-related drug and needle behavior among intravenous drug users
  publication-title: Am J Public Health
  doi: 10.2105/AJPH.81.5.568
  contributor:
    fullname: Stephens
– volume: 74
  start-page: 212
  year: 1995
  ident: R4-12-20210130
  article-title: Correlates of hepatitis C virus infection among injection drug users
  publication-title: Medicine
  doi: 10.1097/00005792-199507000-00005
  contributor:
    fullname: Thomas
– volume: 92
  start-page: 1339
  year: 1997
  ident: R32-12-20210130
  article-title: Social determinants predicting needle-sharing behavior among injection drug users in Vancouver, Canada
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.1997.tb02852.x
  contributor:
    fullname: Strathdee
– year: 1998
  ident: R53-12-20210130
  article-title: Regression analysis of count data
  doi: 10.1017/CBO9780511814365
  contributor:
    fullname: Cameron
– volume: 6
  start-page: 430
  year: 1992
  ident: R2-12-20210130
  article-title: Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme
  publication-title: AIDS
  doi: 10.1097/00002030-199204000-00013
  contributor:
    fullname: Chamot
– volume: 13
  start-page: 73
  year: 2001
  ident: R22-12-20210130
  article-title: Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users
  publication-title: J Subst Abuse
  doi: 10.1016/S0899-3289(01)00071-2
  contributor:
    fullname: Latka
– volume: 136
  start-page: 236
  year: 1992
  ident: R20-12-20210130
  article-title: The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injection drug users, Amsterdam
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a116489
  contributor:
    fullname: Van Ameijden
– volume: 186
  start-page: 1558
  year: 2002
  ident: R11-12-20210130
  article-title: Hepatitis C virus seroconversion among young injection drug users: relationship and risk
  publication-title: J Infect Dis
  doi: 10.1086/345554
  contributor:
    fullname: Hahn
– volume: 9
  start-page: 27
  year: 2005
  ident: R13-12-20210130
  article-title: Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention
  publication-title: AIDS Behav
  doi: 10.1007/s10461-005-1679-y
  contributor:
    fullname: Koester
– start-page: 20
  year: 1995
  ident: R31-12-20210130
  article-title: Using dyadic data for a network analysis of HIV infection and risk behaviors among injecting drug users
  contributor:
    fullname: Neaigus
– volume: 91
  start-page: 42
  year: 2001
  ident: R9-12-20210130
  article-title: Sharing of drug preparation equipment as a risk factor for hepatitis C
  publication-title: Am J Public Health
  doi: 10.2105/AJPH.91.1.42
  contributor:
    fullname: Hagan
– year: 2004
  ident: R52-12-20210130
  article-title: Fitting nonlinear mixed models with the new NLMIXED procedure, version 9.1 software
  contributor:
    fullname: Wolfinger
– volume: 161
  start-page: 1281
  year: 2001
  ident: R15-12-20210130
  article-title: Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.161.10.1281
  contributor:
    fullname: Strathdee
– volume: 75
  start-page: 177
  year: 2004
  ident: R48-12-20210130
  article-title: Association between injection practices and duration of injection among recently initiated injection drug users
  publication-title: Drug Alcohol Depend
  doi: 10.1016/j.drugalcdep.2004.01.014
  contributor:
    fullname: Becker Buxton
– volume: 20
  start-page: 143
  year: 2006
  ident: R55-12-20210130
  article-title: Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials
  publication-title: AIDS
  doi: 10.1097/01.aids.0000196166.48518.a0
  contributor:
    fullname: Crepaz
– volume: 100
  start-page: 150
  year: 2005
  ident: R1-12-20210130
  article-title: Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2004.00963.x
  contributor:
    fullname: Sullivan
– volume: 57
  start-page: 310
  year: 2003
  ident: R6-12-20210130
  article-title: Retrospective cohort study examining incidence of HIV and hepatitis C infection among injecting drug users in Dublin
  publication-title: J Epidemiol Commun Health
  doi: 10.1136/jech.57.4.310
  contributor:
    fullname: Smyth
– volume: 18
  start-page: S11
  year: 1998
  ident: R18-12-20210130
  article-title: Prevalence and incidence of hepatitis C virus infection among young adult injection drug users
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/00042560-199802001-00004
  contributor:
    fullname: Garfein
– volume: 155
  start-page: 645
  year: 2002
  ident: R10-12-20210130
  article-title: Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/155.7.645
  contributor:
    fullname: Thorpe
– volume: 34
  start-page: 346
  year: 1993
  ident: R37-12-20210130
  article-title: HIV sexual risk reduction among college women: applying a peer influence model
  publication-title: J College Stud Dev
  contributor:
    fullname: Kauth
– volume: 280
  start-page: 867
  year: 1998
  ident: R45-12-20210130
  article-title: Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology
  publication-title: Science
  doi: 10.1126/science.280.5365.867
  contributor:
    fullname: Turner
– volume: 4
  start-page: 819
  year: 1990
  ident: R12-12-20210130
  article-title: The limitations of the concept of needle sharing: the practice of ‘frontloading’
  publication-title: AIDS
  doi: 10.1097/00002030-199008000-00020
  contributor:
    fullname: Grund
– volume: 50
  start-page: 1
  issue: RR-19
  year: 2001
  ident: R41-12-20210130
  article-title: Revised guidelines for HIV counseling, testing, and referral and revised recommendations for HIV screening of pregnant women.
  publication-title: MMWR Recomm Rep
– volume: 111
  start-page: 455
  year: 1992
  ident: R43-12-20210130
  article-title: Changing AIDS-risk behavior
  publication-title: Psychol Bull
  doi: 10.1037/0033-2909.111.3.455
  contributor:
    fullname: Fisher
– volume: 317
  start-page: 433
  year: 1998
  ident: R8-12-20210130
  article-title: Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study
  publication-title: BMJ
  doi: 10.1136/bmj.317.7156.433
  contributor:
    fullname: Van Beek
– volume: 80
  start-page: iii7
  year: 2003
  ident: R16-12-20210130
  article-title: The role of sexual transmission of HIV infection among injection and noninjection drug users
  publication-title: J Urban Health
  doi: 10.1093/jurban/jtg078
  contributor:
    fullname: Strathdee
– volume: 81
  start-page: 168
  year: 1991
  ident: R34-12-20210130
  article-title: HIV risk behavior reduction following intervention with key opinion leaders of population: an experimental analysis
  publication-title: Am J Public Health
  doi: 10.2105/AJPH.81.2.168
  contributor:
    fullname: Kelly
– volume: 155
  start-page: 1305
  year: 1995
  ident: R21-12-20210130
  article-title: Temporal trends of incident HIV infection in a cohort of injection drug users in Baltimore, Maryland
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.1995.00430120091011
  contributor:
    fullname: Nelson
– volume: 135
  start-page: 225
  year: 1992
  ident: R19-12-20210130
  article-title: Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The North Italian Seronegative Drug Addicts (NISDA) Study
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a116275
  contributor:
    fullname: Nicolosi
– volume: 88
  start-page: 805
  year: 1993
  ident: R30-12-20210130
  article-title: Needle sharing in context: patterns of sharing among men and women injectors and HIV risks
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.1993.tb02094.x
  contributor:
    fullname: Barnard
– volume: 82
  start-page: 533
  year: 1992
  ident: R26-12-20210130
  article-title: AIDS education for drug users: evaluation of short-term effectiveness
  publication-title: Am J Public Health
  doi: 10.2105/AJPH.82.4.533
  contributor:
    fullname: McClusker
– year: 1986
  ident: R42-12-20210130
  article-title: Social foundations of thought and action
  contributor:
    fullname: Bandura
– volume: 86
  start-page: 655
  year: 1996
  ident: R5-12-20210130
  article-title: Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses
  publication-title: Am J Public Health
  doi: 10.2105/AJPH.86.5.655
  contributor:
    fullname: Garfein
– volume: 353
  start-page: 1657
  year: 1999
  ident: R46-12-20210130
  article-title: Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(98)07026-3
  contributor:
    fullname: Des Jarlais
– volume: 345
  start-page: 41
  year: 2001
  ident: R56-12-20210130
  article-title: Hepatitis C virus infection
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200107053450107
  contributor:
    fullname: Lauer
– volume: 7
  start-page: 719
  year: 1993
  ident: R29-12-20210130
  article-title: Determinants of condom use among intravenous drug users
  publication-title: AIDS
  doi: 10.1097/00002030-199305000-00017
  contributor:
    fullname: Watkins
– volume: 2
  start-page: 253
  year: 1990
  ident: R24-12-20210130
  article-title: Effects of outreach intervention on risk reduction among intravenous drug users
  publication-title: AIDS Educ Prev
  contributor:
    fullname: Neaigus
– volume: 7
  start-page: 403
  year: 1992
  ident: R36-12-20210130
  article-title: School-based substance abuse prevention: a review of the state of the art in curriculum, 1980–1990
  publication-title: Health Educ Res
  doi: 10.1093/her/7.3.403
  contributor:
    fullname: Hansen
– volume: 157
  start-page: 467
  year: 2003
  ident: R23-12-20210130
  article-title: Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwf222
  contributor:
    fullname: Des Jarlais
– volume: 321
  start-page: 874
  year: 1989
  ident: R14-12-20210130
  article-title: Risk factors for human immunodeficiency virus infection in intravenous drug users
  publication-title: N Engl J Med
  doi: 10.1056/NEJM198909283211306
  contributor:
    fullname: Schoenbaum
– volume: 38
  start-page: 963
  year: 1982
  ident: R51-12-20210130
  article-title: Random-effects models for longitudinal data
  publication-title: Biometrics
  doi: 10.2307/2529876
  contributor:
    fullname: Laird
– volume: 42
  start-page: 109
  year: 1980
  ident: R50-12-20210130
  article-title: Regression models for ordinal data (with discussion)
  publication-title: JR Stat Soc Ser B Stat Meth
  contributor:
    fullname: McCullagh
– volume: 113
  start-page: 151
  issue: Suppl 1
  year: 1998
  ident: R35-12-20210130
  article-title: Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users' networks
  publication-title: Public Health Rep
  contributor:
    fullname: Latkin
– volume: 113
  start-page: 42
  year: 1998
  ident: R39-12-20210130
  article-title: Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention
  publication-title: Public Health Rep
  contributor:
    fullname: Broadhead
– volume: 57
  start-page: 307
  year: 1989
  ident: R54-12-20210130
  article-title: Likelihood ratio tests for model selection and nonnested hypotheses
  publication-title: Econometrica
  doi: 10.2307/1912557
  contributor:
    fullname: Vuong
– volume: 357
  start-page: 1397
  year: 2001
  ident: R17-12-20210130
  article-title: Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(00)04562-1
  contributor:
    fullname: Kral
SSID ssj0005088
Score 2.3185341
Snippet To evaluate whether a behavioral intervention, which taught peer education skills, could reduce injection and sexual risk behaviors associated with primary HIV...
Objectives: To evaluate whether a behavioral intervention, which taught peer education skills, could reduce injection and sexual risk behaviors associated with...
SourceID proquest
crossref
pubmed
pascalfrancis
SourceType Aggregation Database
Index Database
StartPage 1923
SubjectTerms Adolescent
Adolescent Behavior - psychology
Adult
Behavior Therapy - methods
Biological and medical sciences
Drug addictions
Female
Health Education - methods
Hepatitis C - epidemiology
Hepatitis C - prevention & control
Hepatitis C virus
HIV Infections - epidemiology
HIV Infections - prevention & control
Human immunodeficiency virus
Human viral diseases
Humans
Incidence
Infectious diseases
Male
Medical sciences
Peer Group
Risk Reduction Behavior
Sexual Behavior - psychology
Substance Abuse, Intravenous - epidemiology
Substance Abuse, Intravenous - psychology
Toxicology
Treatment Outcome
United States - epidemiology
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
Viral hepatitis
Title A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users
URI https://www.ncbi.nlm.nih.gov/pubmed/17721100
https://search.proquest.com/docview/21037452
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFB7WCiKIeO96qfPgWxhNJpfZPIZt7VapILbQtzDXtlJ2l2wi6A_w9_gTPTO5l1WsLyEkZEhyvpz55uQ75yD0ZgYsOpaxJJKGMYko94kwihHpq8TVm0upTU4-_pQsTqMPZ_HZZPJroFqqSvFW_tiaV_I_VoVjYFebJXsDy3aDwgHYB_vCFiwM23-yceattS6IbkUarvhDp2AEVlnYU7YsyFddtwR3SvI2Nd-VYvAWsAC00fMLbcXV5eXGm3vfLouqF2o5MeR36xYGI6miOvdsiGMz5LfZ0f6XYZeQLsxwyAvT9NVscvn7oOshvCQx0pj10m2nC2o1aNkVeKOD3mme19Hbhe2XPQpfMOLaLwy8HE1SAhzJH7rkOmm6hV40cLCWkA4ma0s_t04EdYHhz9l-G-mFpWVoUj_ZUnf72nzYqRTb__MwSn59lFvoNgXX5oQBRx97UZHvOp12D9Uma6bs3bZ7GZGhe2u-ge_S1A1V_rzicczn5AG63yxZcFbj7yGa6OUjdOe4EWU8Rj8zPIYhHsIQlytcwxB34MEWhriDIQYYYoAhBhjiDoZ4jh0McQdD2MMOhoORLAyxg-ETdPr-4GS-IE17DyKjgJZEBMb3jaZUSpaodKa0EMyo1MCcpyPGQysJ0FoyGXAOq2xFlVRKcCOSKJBchk_RznK11LsIKyYt9ZQmlToSKeWhMWEoZazjdDbjYopI-57zdV3FJf-bdadob2SM_qI0AIKesCl63VonB39sf7LxpV5Vm5zaxNsoplP0rDZafy1z0Rb_-Q1v5gW62384L9FOWVT6FTDhUuw58P0GYxm0xQ
link.rule.ids 315,783,787,27936,27937
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+peer-education+intervention+to+reduce+injection+risk+behaviors+for+HIV+and+hepatitis+C+virus+infection+in+young+injection+drug+users&rft.jtitle=AIDS+%28London%29&rft.au=Garfein%2C+Richard+S&rft.au=Golub%2C+Elizabeth+T&rft.au=Greenberg%2C+Alan+E&rft.au=Hagan%2C+Holly&rft.date=2007-09-12&rft.issn=0269-9370&rft.volume=21&rft.issue=14&rft.spage=1923&rft.epage=1932&rft_id=info:doi/10.1097%2FQAD.0b013e32823f9066&rft.externalDBID=n%2Fa&rft.externalDocID=10_1097_QAD_0b013e32823f9066
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0269-9370&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0269-9370&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0269-9370&client=summon